
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis.
The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.
With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
We are seeking a Segment Marketing Manager, Oncology to drive the adoption of Oxford Nanopore sequencing across the clinical and research oncology markets. This is a strategic but highly execution-focused role, responsible not only for helping build the global oncology segment strategy, but for translating that strategy into tangible outputs that accelerate revenue and customer engagement. Please note this role involves up to 40% travel, including internationally.
The Details...
The Segment Marketing Manager will own the development and execution of the global oncology marketing and go-to-market initiatives across critical application areas. You will identify growth opportunities and help shape the global oncology roadmap, while ensuring strong commercial activation across regions. A key focus of this role is enabling the commercial organization in close collaboration with product management through clear value propositions, differentiated positioning, impactful customer-facing materials, structured sales trainings, and practical commercial enablement tools.
This individual will serve as an internal and external subject matter expert for the oncology segment — bringing deep knowledge of market dynamics, competitive landscapes, customer segments, and emerging technologies.
Key Responsibilities
What We’re Looking For...
We offer outstanding benefits to include an attractive bonus and an excellent starting salary. If you are looking to utilise your skills to really make a difference to humankind, then consider joining our team and apply today!
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-JR1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.